Kaplan–Meier survival analysis showed that AML patients with high expression of PRR34‐AS1 had a significantly shorter OS than those with low expression of PRR34‐AS1 (p = 0.002; Figure 1B). This evidence concerns the gene PRR34 and acute myeloid leukemia.